Target intelligence / Profile preview

Bacterial cell wall peptidoglycan synthesis

Molecular classification
Enzyme pathway, Biosynthetic pathway, Other (cell wall biogenesis)
01

Overview

Bacterial cell wall peptidoglycan synthesis refers to the multi-step enzymatic process by which bacteria construct their essential cell wall component, peptidoglycan. Peptidoglycan is a mesh-like polymer composed primarily of alternating N-acetylglucosamine and N-acetylmuramic acid sugars cross-linked by short peptides. This structure provides mechanical strength, maintains cellular shape, and protects bacteria from osmotic lysis. The biosynthetic process involves cytoplasmic formation of nucleotide sugar precursors, membrane-associated assembly into lipid-linked intermediates, and extracellular polymerization with peptide cross-linking catalyzed by transpeptidases known as penicillin-binding proteins. Many clinically important antibiotics—including β-lactams and glycopeptides—target various stages in this pathway because it is essential for bacterial survival but absent in humans. Bacteria can develop resistance through modifications in enzymes or alternative cross-linking mechanisms.

Other names
Peptidoglycan biosynthesisMurein synthesisCell wall biosynthesis (bacteria)PG synthesis
02

Mechanism of action

Inhibition of transpeptidase enzymes (penicillin-binding proteins), blocking cross-linking of peptidoglycan strands; Inhibition of early cytoplasmic steps in precursor formation (e.g., fosfomycin inhibits MurA)

03

Biological functions

Maintenance of cell shape and rigidityProtection against osmotic lysisCell division and binary fissionAdaptation to environmental stress
04

Disease associations

Infection (essential for bacterial viability, thus a target in infectious diseases)
05

Safety considerations

Safety concerns are generally related to the use of drugs targeting this pathway rather than the target itself. Notable issues include antibiotic resistance due to modification or bypassing of peptidoglycan synthesis pathways.
06

Interacting drugs

β-lactam antibiotics (e.g., penicillins, cephalosporins, carbapenems)

3 more in the full profile.

Beyond the preview

Go deeper on Bacterial cell wall peptidoglycan synthesis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial cell wall peptidoglycan synthesis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call